Browsing Tag

OK101

OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 covering OKYO Pharma’s drug candidate…

Jason Junior Dec 14, 2021

LONDON and BOSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular…

Health

OKYO Pharma Limited (“OKYO” or the “Company”) Announces First-in-Class Drug…

Jason Junior Dec 13, 2021

LONDON, Dec. 13, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases (DED) and ocular pain, is…

Health

OKYO Pharma Limited (“OKYO” or the “Company”) to File IND in Q3 2022 for…

Jason Junior Dec 6, 2021

LONDON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), the biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, is…

Newer Posts